He underwent echocardiography on [**2113-4-28**], and the impression from that test was no echocardiographic evidence of inducible ischemia to achieved workload.
A note from this echocardiogram was that based on the [**2109**] AHA endocarditis prophylaxis guidelines, that the echocardiogram findings from this test indicated a moderate risk, and that he should receive prophylaxis in the future.
MEDICATIONS ON ADMISSION:  Meclizine 25 mg p.o.
t.i.d., Cozaar 100 mg p.o.
q.d., atenolol 100 mg p.o.
b.i.d., Isordil 40 mg p.o.
t.i.d., Relafen as needed, aspirin 325 mg p.o.
Based on this, and the patient's history, it was decided that the patient would undergo a coronary artery bypass graft which was planned for the following day.
On [**2113-5-5**], the patient underwent a coronary artery bypass graft times three with internal mammary artery to the left anterior descending artery and saphenous vein graft to the posterior descending artery and the obtuse marginal.
The aortic valve was replaced with a pericardial tissue heart valve of a bovine origin.
One additional note is that, after cardiac catheterization, the patient had an intra-aortic balloon pump placed preoperatively, and then the following morning went to the operating room.
He did receive 1 unit of packed red blood cells.
However, gradually worked with Physical Therapy and was ambulating around the hallway with assistance, and his hematocrit on discharge was 26 and steadily rising.
The patient required aggressive respiratory treatments in order to maintain his oxygen saturations, which he did adequately.
Lopressor 75 mg p.o.
Lasix 20 mg p.o.
Isordil 40 mg p.o.
Lipitor 10 mg p.o.
Meclizine 25 mg p.o.
Cozaar 100 mg p.o.
Percocet 5 one to two tablets p.o.
Aspirin 81 mg p.o.
Colace 100 mg p.o.
Zantac 150 mg p.o.
Dulcolax suppository 10 mg p.r.
Motrin 400 mg p.o.
Serax 15 mg p.o.
Benadryl 25 mg p.o.
Status post coronary artery bypass graft times three.
Status post aortic valve replacement (Bovine).
